Nothing Special   »   [go: up one dir, main page]

ATE62250T1 - Cytidine-diphosphocholine salze, besonders geeignet fuer oralen gebrauch. - Google Patents

Cytidine-diphosphocholine salze, besonders geeignet fuer oralen gebrauch.

Info

Publication number
ATE62250T1
ATE62250T1 AT86108677T AT86108677T ATE62250T1 AT E62250 T1 ATE62250 T1 AT E62250T1 AT 86108677 T AT86108677 T AT 86108677T AT 86108677 T AT86108677 T AT 86108677T AT E62250 T1 ATE62250 T1 AT E62250T1
Authority
AT
Austria
Prior art keywords
salts
diphosphocholine
cytidine
particularly suitable
oral use
Prior art date
Application number
AT86108677T
Other languages
English (en)
Inventor
Federico Gennari
Original Assignee
Bioresearch Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioresearch Spa filed Critical Bioresearch Spa
Application granted granted Critical
Publication of ATE62250T1 publication Critical patent/ATE62250T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
AT86108677T 1985-07-05 1986-06-25 Cytidine-diphosphocholine salze, besonders geeignet fuer oralen gebrauch. ATE62250T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT21447/85A IT1188178B (it) 1985-07-05 1985-07-05 Sali della citidin-difospocolina particolarmente idonei per uso orale
EP86108677A EP0207436B1 (de) 1985-07-05 1986-06-25 Cytidine-diphosphocholine Salze, besonders geeignet für oralen Gebrauch

Publications (1)

Publication Number Publication Date
ATE62250T1 true ATE62250T1 (de) 1991-04-15

Family

ID=11181915

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86108677T ATE62250T1 (de) 1985-07-05 1986-06-25 Cytidine-diphosphocholine salze, besonders geeignet fuer oralen gebrauch.

Country Status (6)

Country Link
US (1) US4789666A (de)
EP (1) EP0207436B1 (de)
JP (1) JPS6212794A (de)
AT (1) ATE62250T1 (de)
DE (1) DE3678498D1 (de)
IT (1) IT1188178B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE105479T1 (de) * 1988-10-27 1994-05-15 Massachusetts Inst Technology Verfahren zur steigerung des phosphatidylcholins in vivo.
KR0177841B1 (ko) * 1992-01-30 1999-04-01 나까무라 간노스께 시티딘 디인산 콜린의 제조방법
CA2094217A1 (en) * 1992-04-17 1993-10-18 Yasutaka Igari Transmucosal therapeutic composition
US6057301A (en) * 1997-12-24 2000-05-02 Interneuron Pharmaceuticals, Inc. Hyperhydrated citicoline, process and use
US7807654B2 (en) * 1998-08-31 2010-10-05 Wellstat Therapeutics Corporation Compositions and methods for treatment of mitochondrial diseases
US7915233B1 (en) 1998-08-31 2011-03-29 Wellstat Therapeutics Corporation Compositions and methods for treatment of mitochondrial diseases
US6472378B2 (en) * 1998-08-31 2002-10-29 Pro-Neuron, Inc. Compositions and methods for treatment of mitochondrial diseases
CN1551778A (zh) * 2001-09-05 2004-12-01 ɽ����ʽ���� 用于糖尿病神经病变的药物组合物
AU2003252488A1 (en) * 2002-07-11 2004-02-02 Yamasa Corporation Medicinal composition for drug-induced neuropathy
WO2005112635A2 (en) * 2004-05-13 2005-12-01 Massachusetts Institute Of Technology Uridine effects on dopamine release

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1189549A (en) * 1967-12-18 1970-04-29 Takeda Chemical Industries Ltd A Method for Production of Cytidine (Deoxycytidine)-5'-Diphosphate Choline and Intermediates therefor
NL149812B (nl) * 1969-04-24 1976-06-15 Takeda Chemical Industries Ltd Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van kristallijn cytidine-5'-difosfaat-choline-monohydraat.
JPS5517769B2 (de) * 1972-01-10 1980-05-14
JPS6043078B2 (ja) * 1980-10-31 1985-09-26 株式会社興人 シチジンジリン酸コリンの製法
CA1188998A (en) * 1980-11-12 1985-06-18 Stephen R. Ash System and method for controlling and monitoring blood or biologic fluid flow
JPS6043079B2 (ja) * 1980-12-25 1985-09-26 株式会社興人 シチジン二リン酸コリンの製造方法
IT1177373B (it) * 1984-12-06 1987-08-26 Bioresearch Spa Sali della 5'-metiltio-5'-deossiadenosina con acidi solfonici a lunga catena alchilica

Also Published As

Publication number Publication date
US4789666A (en) 1988-12-06
IT8521447A0 (it) 1985-07-05
JPH0217559B2 (de) 1990-04-20
EP0207436B1 (de) 1991-04-03
IT1188178B (it) 1988-01-07
DE3678498D1 (de) 1991-05-08
JPS6212794A (ja) 1987-01-21
EP0207436A2 (de) 1987-01-07
EP0207436A3 (en) 1988-01-27

Similar Documents

Publication Publication Date Title
ATE62250T1 (de) Cytidine-diphosphocholine salze, besonders geeignet fuer oralen gebrauch.
DK357585D0 (da) Fremgangsmaade til fremstilling af 2'-deoxyadenosinforbindelser
ES8505518A1 (es) Procedimiento para preparar derivados de aminoacidos
ES8606384A1 (es) Procedimiento para la preparacion de sales de la 5'-metil- tio-5'-deoxiadenosina con acidos sulfonicos de cadena alqui-lica larga
ES2024515B3 (es) Procedimiento para preparar cloruros de retinoilo.
LV5660A3 (lv) Panemiens pretvirusu lidzekla iegusanai
HUT46292A (en) Process for production of new salts of aryl-oxi-propanol-amines formed by diphenyl acetic acid
DE3660591D1 (en) New carnitine salts particularly suitable for oral use
JPS53147026A (en) Continuous preparation of thioglycolic acid
ATE194346T1 (de) Stabile wässrige folinatlösung
GR3001567T3 (en) Process for the preparation of beta-hydroxybutyric acid and its salts by means of hydrolysis of oligomers of beta-hydroxybutyric acid in a basic medium
ES2061484T3 (es) Procedimiento para la preparacion de sales de derivados del acido mercaptoetansulfonico.
AR241134A2 (es) Un procedimiento para preparar w-lactamas
JPS554349A (en) Preparation of creatine
ES542839A0 (es) Procedimiento para la preparacion de sales de carnitina del acido alfa-glucoso-1-fosforico
JPS51113896A (en) Process for preparing adenosine phosphoric acid derivatives
DE3472554D1 (en) Cysteine derivatives, a process for their preparation, and pharmaceutical compostions which contain them
DE3068259D1 (en) Directly injectable aqueous solutions of the alkali salts of canrenoic acid and of furosemide, and process for their production
BG44707A3 (bg) Метод за получаване на 6-деметил-6-дезокси-6-метилен-5- окситетрациклин и негови 11а-хлорни производни
TH2766B (th) เกลือโมโนโซเดียมของกรดเซโฟนิซิค
JPS51136620A (en) Process for preparing inorganic salts of cysteine of high purity.
ES2120403T3 (es) Procedimiento de preparacion de derivados del acido 3,4-dihidroxibutirico opticamente activos.
DE3666952D1 (en) 1-hydroxypyrazole-4-carboxylic acid, process for its preparation and its use
JPS55167274A (en) Forphenicine derivative and its preparation
ES2019885B3 (es) Sal sodica del acido etodolico y procedimiento para su preparacion.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee